CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

Endpoints News
Original article

Soufflé gets $135M for three RNA medicines

Positive
AI Analysis

Summary

Soufflé Therapeutics, a Massachusetts and Germany-based biotech company affiliated with Bob Langer, raised $135 million in Series funding to advance at least three experimental oligonucleotide medicines.

Importance:6/10
Sentiment:
0.70
venture capitalRNA medicineoligonucleotidefinancing

Read the original article

Published by Endpoints News on October 13, 2026 4:54 PM

Read Original